Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) › Shareholders' EquityCordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2020: -$12.8K2021: -$275.8K2022: -$951.3K2023: -$151.8K2024: -$375.5K2025: -$534.6K-$534.6K2020Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$534.6K-42.3%2024-$375.5K-147.4%2023-$151.8K+84.0%2022-$951.3K-244.9%2021-$275.8K-2052.8%2020-$12.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share